Operating Margin of Amylyx Pharmaceuticals, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Amylyx Pharmaceuticals, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Amylyx Pharmaceuticals, Inc. Operating Margin for the quarter ending 30 Sep 2025 was 23660%.
  • Amylyx Pharmaceuticals, Inc. annual Operating Margin for 2023 was 10190%.
  • Amylyx Pharmaceuticals, Inc. annual Operating Margin for 2022 was -906%, a 97% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Amylyx Pharmaceuticals, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 23660% +23799% 01 Jul 2025 30 Sep 2025
Q2 2025 79106% +79166% 01 Apr 2025 30 Jun 2025
Q1 2025 18114% +18134% 01 Jan 2025 31 Mar 2025
Q4 2024 -360% -370% -3635% 01 Oct 2024 31 Dec 2024
Q3 2024 -139% 01 Jul 2024 30 Sep 2024
Q2 2024 -60% 01 Apr 2024 30 Jun 2024
Q1 2024 -20% 01 Jan 2024 31 Mar 2024
Q4 2023 10% 01 Oct 2023 31 Dec 2023

Amylyx Pharmaceuticals, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 10190% +11096% 01 Jan 2023 31 Dec 2023
2022 -906% +28108% +97% 01 Jan 2022 31 Dec 2022
2021 -29013% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.